|
Adrian SG, Perez CI, Carmona-Bayonas A, Moran LO, Perez JR, Del Prado PM, De Castro EM, Neria F, Perez IF, De Herreros MG, Campos MC, Escobar IG, Balanya RP, Gonzalez DM, Fonseca PJ, Garcia MEG, Canovas MS, Langa JM, Segura PP, Vidal MJM, Martin AJM, Medical Oncology SSO. Cancer-related thrombosis: impact of biological sex on the risk of rethrombosis and bleeding. Haematologica. 2025 Jul 1;110(7):1513-1522. doi: 10.3324/haematol.2024.286152. Epub 2024 Dec 12. PubMed PMID: 39665199; PubMed Central PMCID: PMC12208159.
AÑO: 2025; IF: 7.9
|
39665199
|
Mateos L, Jimenez-Fonseca P, Gallego J, Lecumberri A, Custodio A, Martinez de Castro E, Hernandez San Gil R, Fernandez Montes A, Limon ML, Vidal-Tocino R, Cano JM, Lopez Robles J, Gil M, Acosta Eyzaguirre D, Marin Zafra G, Merida-Garcia AJ, Francisco Fernandez A, Ribera Fernandez P, Hierro C, Riesco MC, Garcia Araque M, Ruiz Martin M, Pimentel P, Visa L, Cerda P, Granja M, Ruperez Blanco AB, Gutierrez L, Carmona-Bayonas A. Does perioperative FLOT increase cure rates in resectable esophageal adenocarcinoma? A mixture cure model analysis. Br J Cancer. 2025 Nov 26. doi: 10.1038/s41416-025-03264-2. Online ahead of print. PubMed PMID: 41298815.
AÑO: 2025; IF: 6.8
|
|
Salazar R, Carmona-Bayonas A. Toward risk-adjusted CT schedules in first-line metastatic colorectal cancer. Ann Oncol. 2025 Nov;36(11):1239-1241. doi: 10.1016/j.annonc.2025.09.010. Epub 2025 Sep 23. No abstract available. PubMed PMID: 40998093.
AÑO: 2025; IF: 65.4
|
|
Jimenez-Fonseca P, Carmona-Bayonas A, Alvarez-Canada J, Storfer-Isser A, Martin-Richard M, Sauri T, Cano JM, Martinez Moreno E, Perez-Wert P, Lopez J, Garcia Navalon F, Gomez-Gonzalez L, Ruiz Martin M, Ruperez Blanco AB, Lopez-Lopez F, Roncancio-Diaz E, Corbacho B, Mateo M, Anguita-Alonso P, Gallego Plazas J. Treatment and Outcomes in Advanced Gastroesophageal Adenocarcinoma in the Pre-Immunotherapy Era Based on the Spanish AGAMENON-SEOM Registry. Cancers (Basel). 2025 Jun 27;17(13):2164. doi: 10.3390/cancers17132164. PubMed PMID: 40647463; PubMed Central PMCID: PMC12248623.
AÑO: 2025; IF: 4.4
|
|
Garcia-Alfonso P, Jimenez-Fonseca P, Soto-Alsar J, Baraibar I, Santos C, La Casta A, Ghanem I, Pulido Cortijo G, Marino Mendez A, Pazo-Cid R, Vera R, Melian M, Alcaide J, Grana B, Paez D, Gallego I, Lobo M, Borregon M, Fernandez Montes A, Martinez de Castro E, Carmona-Bayonas A, Aranda E. Three-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 study. Oncologist. 2025 Aug 4;30(8):oyae300. doi: 10.1093/oncolo/oyae300. PubMed PMID: 39550209; PubMed Central PMCID: PMC12395236.
AÑO: 2025; IF: 4.2
|